Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Allergy & Clinical Immunology

Philip Goulder, a professor of immunology at the University of Oxford, is currently investigating why a significant subsection of HIV-positive children in sub-Saharan Africa seem to have resisted the...
A 41-year-old man with HIV apparently developed cancer from a parasitic tapeworm undergoing a malignant process.
TXA-709 is a new type of antibiotic being developed by TAXIS Pharmaceuticals. The antibiotic specifically targets variants of the MRSA bacteria. TXA-709, a FtsZ-targeting benzamide prodrug, should be able to circumvent the problem of antibiotic resistance...